abstract |
The present invention relates generally to novel antiviral agents. Specifically, the present invention relates to compounds that can inhibit the protein encoded by hepatitis B virus (HBV) or interfere with the function of the replication cycle of HBV, compositions containing these compounds, methods for inhibiting replication of HBV virus, for treatment or Methods for preventing HBV infection, as well as methods and intermediates for making these compounds. |